Current  ||| S:0 E:8 ||| JJ
management  ||| S:8 E:19 ||| NN
approaches  ||| S:19 E:30 ||| NNS
to  ||| S:30 E:33 ||| TO
portopulmonary  ||| S:33 E:48 ||| FW
hypertension  ||| S:48 E:61 ||| FW
Portopulmonary  ||| S:61 E:76 ||| FW
hypertension  ||| S:76 E:89 ||| FW
( ||| S:89 E:90 ||| -LRB-
PoPH ||| S:90 E:94 ||| NNP
)  ||| S:94 E:96 ||| -RRB-
is  ||| S:96 E:99 ||| VBZ
a  ||| S:99 E:101 ||| DT
rare  ||| S:101 E:106 ||| JJ
but  ||| S:106 E:110 ||| CC
life-threatening  ||| S:110 E:127 ||| JJ
complication  ||| S:127 E:140 ||| NN
of  ||| S:140 E:143 ||| IN
portal  ||| S:143 E:150 ||| JJ
hypertension  ||| S:150 E:163 ||| NN
that  ||| S:163 E:168 ||| WDT
is  ||| S:168 E:171 ||| VBZ
characterised  ||| S:171 E:185 ||| VBN
by  ||| S:185 E:188 ||| IN
proliferative  ||| S:188 E:202 ||| JJ
changes  ||| S:202 E:210 ||| NNS
in  ||| S:210 E:213 ||| IN
the  ||| S:213 E:217 ||| DT
pulmonary  ||| S:217 E:227 ||| JJ
microvasculature  ||| S:227 E:244 ||| JJ
indistinguishable  ||| S:244 E:262 ||| NN
from  ||| S:262 E:267 ||| IN
other  ||| S:267 E:273 ||| JJ
forms  ||| S:273 E:279 ||| NNS
of  ||| S:279 E:282 ||| IN
pulmonary  ||| S:282 E:292 ||| FW
arterial  ||| S:292 E:301 ||| FW
hypertension  ||| S:301 E:314 ||| FW
( ||| S:314 E:315 ||| -LRB-
PAH ||| S:315 E:318 ||| NNP
) ||| S:318 E:319 ||| -RRB-
.  ||| S:319 E:321 ||| .
Although  ||| S:321 E:330 ||| IN
PoPH  ||| S:330 E:335 ||| NNP
is  ||| S:335 E:338 ||| VBZ
most  ||| S:338 E:343 ||| RBS
commonly  ||| S:343 E:352 ||| RB
observed  ||| S:352 E:361 ||| VBN
in  ||| S:361 E:364 ||| IN
the  ||| S:364 E:368 ||| DT
setting  ||| S:368 E:376 ||| NN
of  ||| S:376 E:379 ||| IN
cirrhosis ||| S:379 E:388 ||| NN
,  ||| S:388 E:390 ||| ,
patients  ||| S:390 E:399 ||| NNS
with  ||| S:399 E:404 ||| IN
non-cirrhotic  ||| S:404 E:418 ||| JJ
portal  ||| S:418 E:425 ||| JJ
hypertension  ||| S:425 E:438 ||| NNS
are  ||| S:438 E:442 ||| VBP
also  ||| S:442 E:447 ||| RB
at  ||| S:447 E:450 ||| IN
risk  ||| S:450 E:455 ||| NN
of  ||| S:455 E:458 ||| IN
developing  ||| S:458 E:469 ||| VBG
the  ||| S:469 E:473 ||| DT
disorder ||| S:473 E:481 ||| NN
.  ||| S:481 E:483 ||| .
A  ||| S:483 E:485 ||| DT
definitive  ||| S:485 E:496 ||| JJ
diagnosis  ||| S:496 E:506 ||| NN
requires  ||| S:506 E:515 ||| VBZ
invasive  ||| S:515 E:524 ||| JJ
haemodynamic  ||| S:524 E:537 ||| JJ
confirmation  ||| S:537 E:550 ||| NN
by  ||| S:550 E:553 ||| IN
right  ||| S:553 E:559 ||| JJ
heart  ||| S:559 E:565 ||| NN
catheterisation  ||| S:565 E:581 ||| NNS
and  ||| S:581 E:585 ||| CC
screening  ||| S:585 E:595 ||| NN
for  ||| S:595 E:599 ||| IN
PoPH  ||| S:599 E:604 ||| NNP
should  ||| S:604 E:611 ||| MD
be  ||| S:611 E:614 ||| VB
routinely  ||| S:614 E:624 ||| RB
performed  ||| S:624 E:634 ||| VBN
in  ||| S:634 E:637 ||| IN
all  ||| S:637 E:641 ||| DT
patients  ||| S:641 E:650 ||| NNS
being  ||| S:650 E:656 ||| VBG
considered  ||| S:656 E:667 ||| VBN
for  ||| S:667 E:671 ||| IN
liver  ||| S:671 E:677 ||| JJ
transplantation ||| S:677 E:692 ||| NN
.  ||| S:692 E:694 ||| .
Although  ||| S:694 E:703 ||| IN
severe  ||| S:703 E:710 ||| JJ
PoPH  ||| S:710 E:715 ||| NN
is  ||| S:715 E:718 ||| VBZ
considered  ||| S:718 E:729 ||| VBN
a  ||| S:729 E:731 ||| DT
contraindication  ||| S:731 E:748 ||| NN
to  ||| S:748 E:751 ||| TO
liver  ||| S:751 E:757 ||| VB
transplantation ||| S:757 E:772 ||| NN
,  ||| S:772 E:774 ||| ,
there  ||| S:774 E:780 ||| EX
is  ||| S:780 E:783 ||| VBZ
now  ||| S:783 E:787 ||| RB
compelling  ||| S:787 E:798 ||| JJ
data  ||| S:798 E:803 ||| NNS
supporting  ||| S:803 E:814 ||| VBG
the  ||| S:814 E:818 ||| DT
use  ||| S:818 E:822 ||| NN
of  ||| S:822 E:825 ||| IN
PAH-specific  ||| S:825 E:838 ||| JJ
therapies  ||| S:838 E:848 ||| NNS
with  ||| S:848 E:853 ||| IN
the  ||| S:853 E:857 ||| DT
aim  ||| S:857 E:861 ||| NN
of  ||| S:861 E:864 ||| IN
improving  ||| S:864 E:874 ||| VBG
pulmonary  ||| S:874 E:884 ||| JJ
haemodynamics  ||| S:884 E:898 ||| NN
to  ||| S:898 E:901 ||| TO
allow  ||| S:901 E:907 ||| VB
transplantation  ||| S:907 E:923 ||| VBN
to  ||| S:923 E:926 ||| TO
be  ||| S:926 E:929 ||| VB
successfully  ||| S:929 E:942 ||| RB
performed ||| S:942 E:951 ||| VBN
.  ||| S:951 E:953 ||| .
This  ||| S:953 E:958 ||| DT
review  ||| S:958 E:965 ||| NN
explores  ||| S:965 E:974 ||| VBZ
possible  ||| S:974 E:983 ||| JJ
relevant  ||| S:983 E:992 ||| JJ
aetiological  ||| S:992 E:1005 ||| JJ
factors  ||| S:1005 E:1013 ||| NNS
and  ||| S:1013 E:1017 ||| CC
summarises  ||| S:1017 E:1028 ||| JJ
current  ||| S:1028 E:1036 ||| JJ
diagnostic  ||| S:1036 E:1047 ||| JJ
and  ||| S:1047 E:1051 ||| CC
therapeutic  ||| S:1051 E:1063 ||| JJ
approaches  ||| S:1063 E:1074 ||| NNS
for  ||| S:1074 E:1078 ||| IN
PoPH  ||| S:1078 E:1083 ||| JJ
patients ||| S:1083 E:1091 ||| NNS
.  ||| S:1091 E:1093 ||| .
